JCDSA  Vol.5 No.1 , March 2015
Therapeutic Role of Isotretinoin in the Management of Recurrent Aphthous Stomatitis (Single-Blind Controlled Therapeutic Study)
Abstract: Background: Recurrent aphthous ulcer (RAS) is a common oral disease where its etiopathogenesis is not well elucidated. There was no effective curative therapy for this disease. Isotretinoin has been recently used in the treatment of Behcet’s disease. Objectives: To evaluate the efficacy and safety of isotretinoin in treating RAS and the long term remission of RAS. Patients and Methods: This single-blind controlled therapeutic study conducted in Department of Dermatology-Baghdad Teaching Hospital during February 2011-January 2012. Thirty patients with typical RAS were included in this work. Detailed history and full examination were done for all patients. They were given isotretinoin 20 mg orally once daily for three months to be seen on Day 14 firstly and then monthly to be assessed using the oral clinical manifestation index (OCMI). After isotretinoin was stopped three months later, patients were given placebo therapy for another 3 months. Results: The results of 30 treated patients were as follows: 17 (56.67%) males and 13 (43.33%) females with male to female ratio was 1.3:1. Their ages ranged from 12 - 60 (35.33 ± 12.06) years. The OCMI before isotretinoin therapy ranged from 7 - 17 (13.13 ± 2.55), while after therapy the mean started to decline to a lower level within the first 14 days (P = 0.103), and continued to decline significantly until the end of the first month of therapy (P = 0.023). Then the OCMI declined very significantly until the end of fourth month of therapy (P < 0.001). After that the mean started to increase until the end of the 5 months (with placebo) but it remained statistically significant compared with the baseline of mean of OCMI before treatment (P = 0.046). Then it continued to increase to become not significant at the end of 6 months of therapy (P = 0.107). Conclusion: Isotretinoin is an effective therapeutic and prophylactic promising remedy in treatment of RAS.
Cite this paper: Sharquie, K. , Helmi, R. , Noaimi, A. , Kadhom, M. and Al-Hayani, R. (2015) Therapeutic Role of Isotretinoin in the Management of Recurrent Aphthous Stomatitis (Single-Blind Controlled Therapeutic Study). Journal of Cosmetics, Dermatological Sciences and Applications, 5, 15-21. doi: 10.4236/jcdsa.2015.51003.

[1]   Cawson, R.A., Odell, E.W. and Porter, S.R. (2002) Cawson’s Essentials of Oral Pathology and Oral Medicine. 7th Edition, Churchill Livingstone, New York.

[2]   Natah, S.S., Konttinen, Y.T., Enattah, N.S., Ashammakhi, N., Sharkey, K.A. and Hayrinen Immonen, R. (2004) Recurrent Aphthou Ulcers Today: A Review of the Growing Knowledge. International Journal of Oral and Maxillofacial Surgery, 33, 221-234.

[3]   Rivera Hidalgo, F., Shulman, J.D. and Beach, M.M. (2004) The Association of Tobacco and Other Factors with Recurrent Aphthous Stomatitis in an US Adult Population. Oral Diseases, 10, 335-345.

[4]   Katz, J., Chaushu, G. and Peretz, B. (2001) Recurrent Oral Ulcerations Associated with Recurrent Herpes Labialis— Two Distinct Entities? Community Dentistry and Oral Epidemiology, 29, 260-263.

[5]   Sun, A., Chia, J.S. and Chiang, C.P. (2002) Increased Proliferative Response of Peripheral Blood Mononuclear Cells and T Cells to Streptococcus mutans and Glucosyltransferase D Antigens in the Exacerbation Stage of Recurrent Aphthous Ulcerations. Journal of the Formosan Medical Association, 101, 560-566.

[6]   Fawaz, A. (2003) Cytological Cytogenetic and Biochemical Analysis of Behcet’s Disease and Recurrent Aphthous Stomatitis. A Thesis Submitted to the College of Dentistry University of Baghdad in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Oral Medicine, 44-55.

[7]   Pedersen, A. and Horsleth, A. (1993) Recurrent Aphthous Ulceration: A Possible Clinical Manifestation of Reaction of Varicella Zoster of Cytomegalovirus Infection. Journal of Oral Pathology & Medicine, 22, 64-68.

[8]   Jurge, S., Kuffer, R., Scully, C. and Porter, S.R. (2006) Mucosal Disease Series. Number VI. Recurrent Aphthous Stomatitis. Oral Diseases, 12, 1-21.

[9]   Buno, I.J., Huff, J.C. and Weston, W.L. (1998) Elevated Levels of Interferon Gamma, Tumor Necrosis Factor α, Interleukin 2, 4, and 5, but Not Interleukin 10, Are Present in Recurrent Aphthous Stomatitis. Archives of Dermatology, 134, 827-831.

[10]   Bazrafshani, M.R., Hajeer, A.H., Ollier, W.E. and Thornhill, M.H. (2002) IL1B and IL6 Gene Polymorphisms Encode Significant Risk for the Development of Recurrent Aphthous Stomatitis (RAS). Genes & Immunity, 3, 302-305.

[11]   Kozlak, S.T., Walsh, S.J. and Lalla, R.V. (2010) Reduced Dietary Intake of Vitamin B12 and Folate in Patients with Recurrent Aphthous Stomatitis. Journal of Oral Pathology & Medicine, 39, 420-423.

[12]   Jacobson, J.M., Greenspan, J.S., Spritzler, J., Ketter, N., Fahey, J.L. and Jackson, J.B. (1997) Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection. National Institutes of Allergy and Infectious Diseases AIDS Clinical Trials Group. The New England Journal of Medicine, 336, 1487-1493.

[13]   Demiroglu, H. and Dunder, S. (1997) Behcet’s Disease and Chronic Neutropenia. Scandinavian Journal of Rheumatology, 26, 130-132.

[14]   Burns, D.A. and Breathnach, S.M. (2004) Recurrent Aphthous Stomatitis. In: Cox, N. and Griffiths, C., Eds., Rook’s Textbook of Dermatology, Blackwell Publishing, Oxford, 43-46.

[15]   Barrons, R.W. (2001) Treatment Strategies for Recurrent Oral Aphthous Ulcers. American Journal of Health-System Pharmacy, 58, 41-50.

[16]   William, D.J., Timothy, G.B. and Dirk, M.E. (2006) Recurrent Aphthous Stomatitis. Andrew’s Disease of the Skin: Clinical Dermatology. 10th Edition, WB Saunders Company, Philadelphia, 810-812.

[17]   Sharquie, K.E. and Najim, R.A. (2001) Honey as a New Skin Tissue Preservative. Pan Arab League of Dermatologists, 12, 49-54.

[18]   Sharquie, K.E., Al Tammimi, S.M., Al Mashhadani, S., Hayani, R.K. and Al-Nuaimi, A.A. (2006) Lactic Acid 5 Percent Mouthwash Is an Effective Mode of Therapy in Treatment of Recurrent Aphthous Stomatitis. Dermatology Online Journal, 12, 2.

[19]   Abdoli, S., Hadi, N., Ali, A., Waiz, M. and Hayani, R. (2004) A Comparative Study in the Effect of Nigella Sativa Oil, Eugenol and Betamethasone in the Treatment of Recurrent Oral Ulcerations. Clinical and Experimental Rheumatology Journal, 22, 120.

[20]   Al Na’mah, Z.M., Carson, R. and Thanoon, I.A. (2009) Dexamucobase: A Novel Treatment for Oral Aphthous Ulceration. Quintessence International, 40, 399-404.

[21]   Babaee, N., Mansourian, A., Momen Heravi, F., Moghadamnia, A. and Momen Beitollahi, J. (2010) The Efficacy of a Paste Containing Myrtus communis (Myrtle) in the Management of Recurrent Aphthous Stomatitis: A Randomized Controlled Trial. Clinical Oral Investigations, 14, 65-70.

[22]   Fontes, V., Machet, L., Huttenberger, B., Lorette, G. and Vaillant, L. (2002) Recurrent Aphthous Stomatitiis: Treatment with Colchicines. An Open Trial of 54 Cases. Annales de Dermatologie et de Venereologie, 129, 1365-1369.

[23]   Scully, C. (2006) Clinical Practice. Aphthous Ulceration. The New England Journal of Medicine, 355, 165-172.

[24]   Sharquie, K.E. and Hayani, R.K. (2005) BCG as a New Therapeutic and Prophylactic Agent in Patients with Severe Oral Aphthosis. Clinical and Experimental Rheumatology Journal, 23, 914.

[25]   Sfikakis, P.P., Markomichelakis, N., Alpsoy, E., et al. (2007) Anti-TNF Therapy in the Management of Behcet’s Disease: Review and Basis for Recommendations. Rheumatology (Oxford), 46, 736-741.

[26]   Sharquie, K.E., Najim, R.A., Al Hayani, R.K., Al Nuaimi, A.A. and Maroof, D.M. (2008) The Therapeutic and Prophylactic Role of Oral Zinc Sulfate in Treatment of Recurrent Aphthous Stomatitis in Comparison with Dapsone. Saudi Medical Journal, 29, 734-738.

[27]   Kontaxakis, V.P., Skourides, D., Ferentinos, P., Havaki-Kontaxaki, B.J. and Papadimitriou, G.N. (2009) Isotretinoin and Psychopathology: A Review. Annals of General Psychiatry, 8, 2.

[28]   Chandraratna, R.A. (1998) Rational Design of Receptor-Selective Eretinoids. Journal of the American Academy of Dermatology, 39, 124-128.

[29]   Fathy, A., Mohamed, R.W., Ismael, N.A. and El Akhras, M.A. (2009) Expression of Toll-Like Receptor 2 on Peripheral Blood Monocytes of Patients with Inflammatory and Noninflammatory Acne Vulgaris. Egyptian Journal of Immunology, 16, 127-134.

[30]   Czeczuga Semeniuk, E., Anchim, T., Dzieciol, J., Dabrowska, M. and Wonczyński, S. (2004) Can Transforming Growth Factor-Beta1 and Retinoids Modify the Activity of Estradiol and Antiestrogens in MCF-7 Breast Cancer Cells? Acta Biochimica Polonica, 51, 733-745.

[31]   Sharquie, K.E., Helmi, R.M.A., Noaimi, A.A., Al Hayani, R.K. and Khadom, M.A.A. (2013) The Therapeutic Role of Isotretinoin in the Management of Bahcet Disease: A Single-Blind, Controlled Therapeutic Study. Journal of Drugs in Dermatology, 12, e68-e73.

[32]   Malvasi, A., Tinelli, A., Buia, A. and De Luca, G.F. (2009) Possible Long Term Teratogenic Effect of Isotretinoin in Pregnancy. European Review of Medical and Phamacological Sciences, 13, 393-396.

[33]   Sampaio, S.P.A. and Rivitti, E.A. (2001) Dermatologia. Artes Médicas, Sao Paulo.

[34]   Soprano, D.R. and Blaner, W.S. (1994) Plasma Delivery of Retinoic Acid to Tissues in the Rat. In: Sporn, M.B., Roberts, A.B. and Goodman, D.S., Eds., The Retinoids, Biology, Chemistry and Medicine, 2nd Edition, Raven Press, Ltd., New York, 257-282.

[35]   McNamara, P.J., Jewell, R.C., Jensen, B.K., et al. (1988) Food Increases the Bioavailability of Acitretin. The Journal of Clinical Pharmacology, 28, 1051-1055.